ATR inhibition sensitizes HPV− and HPV+ head and neck squamous cell carcinoma to cisplatin

Title
ATR inhibition sensitizes HPV− and HPV+ head and neck squamous cell carcinoma to cisplatin
Authors
Keywords
ATR, Cisplatin, AZD6738, HNSCC
Journal
ORAL ONCOLOGY
Volume 95, Issue -, Pages 35-42
Publisher
Elsevier BV
Online
2019-06-06
DOI
10.1016/j.oraloncology.2019.05.028

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started